A Study Evaluating the Safety and Efficacy of SM04690 for the Treatment of Moderately to Severely Symptomatic Knee Osteoarthritis

NCT03122860 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

700

Enrollment

INDUSTRY

Sponsor class

Conditions

Knee Osteoarthritis

Interventions

DRUG: SM04690
OTHER: Placebo
OTHER: Sham

Sponsor

Biosplice Therapeutics, Inc.